{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T19:35:30Z","timestamp":1774294530632,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T00:00:00Z","timestamp":1593993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T00:00:00Z","timestamp":1593993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Renal loss of potassium (K<jats:sup>+<\/jats:sup>) and magnesium (Mg<jats:sup>2+<\/jats:sup>) in salt losing tubulopathies (SLT) leads to significantly reduced Quality of Life (QoL) and higher risks of cardiac arrhythmia. The normalization of K<jats:sup>+<\/jats:sup> is currently the most widely accepted treatment target, however in even excellently designed RCTs the increase of K<jats:sup>+<\/jats:sup> was only mild and rarely normalized. These findings question the role of K<jats:sup>+<\/jats:sup> as the ideal marker of potassium homeostasis in SLT. Aim of this hypothesis-generating study was to define surrogate endpoints for future treatment trials in SLT in terms of their usefulness to determine QoL and important clinical outcomes.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Within this prospective cross-sectional study including 11 patients with SLTs we assessed the biochemical, clinical and cardiological parameters and their relationship with QoL (RAND SF-36). The primary hypothesis was that QoL would be more dependent of higher aldosterone concentration, assessed by the transtubular-potassium-gradient (TTKG). Correlations were evaluated using Pearson\u2019s correlation coefficient.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Included patients were mainly female (82%, mean age 34\u2009\u00b1\u200912\u2009years). Serum K<jats:sup>+<\/jats:sup> and Mg<jats:sup>2+<\/jats:sup> was 3.3\u2009\u00b1\u20090.6\u2009mmol\/l and 0.7\u2009\u00b1\u20090.1\u2009mmol\/l (mean\u2009\u00b1\u2009SD). TTKG was 9.5\/3.4\u201320.2 (median\/range). While dimensions of mental health mostly correlated with serum Mg<jats:sup>2+<\/jats:sup> (r\u2009=\u20090.68, <jats:italic>p<\/jats:italic>\u00a0=\u20090.04) and K<jats:sup>+<\/jats:sup> (r\u2009=\u20090.55, <jats:italic>p<\/jats:italic>\u00a0=\u20090.08), better physical health was associated with lower aldosterone levels (r\u2009=\u2009-0.61, <jats:italic>p<\/jats:italic>\u00a0=\u20090.06). TTKG was neither associated with aldosterone levels nor with QoL parameters. No relevant abnormalities were observed in neither 24\u2009h-ECG nor echocardiography.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Hyperaldosteronism, K<jats:sup>+<\/jats:sup> and Mg<jats:sup>2+<\/jats:sup> were the most important parameters of QoL. TTKG was no suitable marker for hyperaldosteronism or QoL. Future confirmatory studies in SLT should assess QoL as well as aldosterone, K<jats:sup>+<\/jats:sup> and Mg<jats:sup>2+<\/jats:sup>.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12882-020-01905-7","type":"journal-article","created":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T11:03:50Z","timestamp":1594033430000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Markers of potassium homeostasis in salt losing tubulopathies- associations with hyperaldosteronism and hypomagnesemia"],"prefix":"10.1186","volume":"21","author":[{"given":"Michael","family":"Eder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Darmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria C.","family":"Haller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marija","family":"Bojic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Peck-Radosavljevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Huditz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregor","family":"Bond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Vychytil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman","family":"Reindl-Schwaighofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0093-5389","authenticated-orcid":false,"given":"\u017deljko","family":"Kiki\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,6]]},"reference":[{"issue":"1","key":"1905_CR1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.kint.2016.09.046","volume":"91","author":"A Blanchard","year":"2017","unstructured":"Blanchard A, Bockenhauer D, Bolignano D, et al. Gitelman syndrome: consensus and guidance from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int. 2017;91(1):24\u201333.","journal-title":"Kidney Int"},{"issue":"10","key":"1905_CR2","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1093\/qjmed\/hcq123","volume":"103","author":"G Graziani","year":"2010","unstructured":"Graziani G, Fedeli C, Moroni L, Cosmai L, Badalamenti S, Ponticelli C. Gitelman syndrome: pathophysiological and clinical aspects. QJM. 2010;103(10):741\u20138.","journal-title":"QJM."},{"issue":"7","key":"1905_CR3","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1093\/ndt\/13.7.1617","volume":"13","author":"L Monnens","year":"1998","unstructured":"Monnens L, Bindels R, Grunfeld JP. Gitelman syndrome comes of age. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 1998;13(7):1617\u20139.","journal-title":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association."},{"issue":"3","key":"1905_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000185159","volume":"50","author":"JB Puschett","year":"1988","unstructured":"Puschett JB, Greenberg A, Mitro R, Piraino B, Wallia R. Variant of Bartter's syndrome with a distal tubular rather than loop of Henle defect. Nephron. 1988;50(3):205\u201311.","journal-title":"Nephron."},{"issue":"11","key":"1905_CR5","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1097\/00007611-197811000-00008","volume":"71","author":"GL Barbour","year":"1978","unstructured":"Barbour GL, Day JO. Asymptomatic Bartter's syndrome. South Med J. 1978;71(11):1341 -1344, 1349.","journal-title":"South Med J"},{"issue":"2","key":"1905_CR6","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1046\/j.1523-1755.2001.059002710.x","volume":"59","author":"DN Cruz","year":"2001","unstructured":"Cruz DN, Shaer AJ, Bia MJ, et al. Gitelman's syndrome revisited: an evaluation of symptoms and health-related quality of life. Kidney Int. 2001;59(2):710\u20137.","journal-title":"Kidney Int"},{"issue":"2","key":"1905_CR7","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1681\/ASN.2014030293","volume":"26","author":"A Blanchard","year":"2015","unstructured":"Blanchard A, Vargas-Poussou R, Vallet M, et al. Indomethacin, amiloride, or eplerenone for treating hypokalemia in Gitelman syndrome. J Am Soc Nephrol. 2015;26(2):468\u201375.","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"1905_CR8","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1681\/ASN.2007070792","volume":"18","author":"CL Huang","year":"2007","unstructured":"Huang CL, Kuo E. Mechanism of hypokalemia in magnesium deficiency. J Am Soc Nephrol. 2007;18(10):2649\u201352.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"1905_CR9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.5414\/CNP67193","volume":"67","author":"R Scognamiglio","year":"2007","unstructured":"Scognamiglio R, Negut C, Calo LA. Aborted sudden cardiac death in two patients with Bartter's\/Gitelman's syndromes. Clin Nephrol. 2007;67(3):193\u20137.","journal-title":"Clin Nephrol"},{"issue":"4","key":"1905_CR10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0272-6386(12)80076-X","volume":"15","author":"JH Ethier","year":"1990","unstructured":"Ethier JH, Kamel KS, Magner PO, Lemann J Jr, Halperin ML. The transtubular potassium concentration in patients with hypokalemia and hyperkalemia. Am J Kidney Dis. 1990;15(4):309\u201315.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"1905_CR11","first-page":"234","volume":"12","author":"ML West","year":"1986","unstructured":"West ML, Marsden PA, Richardson RM, Zettle RM, Halperin ML. New clinical approach to evaluate disorders of potassium excretion. Miner Electrolyte Metab. 1986;12(4):234\u20138.","journal-title":"Miner Electrolyte Metab"},{"issue":"3","key":"1905_CR12","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1681\/ASN.2007091017","volume":"19","author":"MJ Choi","year":"2008","unstructured":"Choi MJ, Ziyadeh FN. The utility of the transtubular potassium gradient in the evaluation of hyperkalemia. J Am Soc Nephrol. 2008;19(3):424\u20136.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"1905_CR13","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1034\/j.1600-0676.2001.01693.x","volume":"22","author":"YS Lim","year":"2002","unstructured":"Lim YS, Han JS, Kim KA, Yoon JH, Kim CY, Lee HS. Monitoring of transtubular potassium gradient in the diuretic management of patients with cirrhosis and ascites. Liver. 2002;22(5):426\u201332.","journal-title":"Liver."},{"key":"1905_CR14","doi-asserted-by":"crossref","unstructured":"Hays RD, Sherbourne CD, Mazel RM. The RAND 36-item health survey 1.0. Health Econ 1993;2(3):217\u2013227.","DOI":"10.1002\/hec.4730020305"},{"issue":"6846","key":"1905_CR15","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1136\/bmj.305.6846.160","volume":"305","author":"JE Brazier","year":"1992","unstructured":"Brazier JE, Harper R, Jones NM, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992;305(6846):160\u20134.","journal-title":"BMJ."},{"key":"1905_CR16","volume-title":"Methodische Betrachtungen zu den Summenscores des SF-36 anhand der erwachsenen bundesdeutschen Bev\u00f6lkerung","author":"U Ellert","year":"2004","unstructured":"Ellert U, Kurth B-M. Methodische Betrachtungen zu den Summenscores des SF-36 anhand der erwachsenen bundesdeutschen Bev\u00f6lkerung. Robert Koch-Institut, Epidemiologie und Gesundheitsberichterstattung: In; 2004."},{"issue":"2","key":"1905_CR17","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1046\/j.1523-1755.2002.00467.x","volume":"62","author":"A Bettinelli","year":"2002","unstructured":"Bettinelli A, Tosetto C, Colussi G, Tommasini G, Edefonti A, Bianchetti MG. Electrocardiogram with prolonged QT interval in Gitelman disease. Kidney Int. 2002;62(2):580\u20134.","journal-title":"Kidney Int"},{"issue":"6","key":"1905_CR18","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1093\/ndt\/gfh204","volume":"19","author":"PE Foglia","year":"2004","unstructured":"Foglia PE, Bettinelli A, Tosetto C, et al. Cardiac work up in primary renal hypokalaemia-hypomagnesaemia (Gitelman syndrome). Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2004;19(6):1398\u2013402.","journal-title":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association"},{"issue":"6","key":"1905_CR19","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.jclinepi.2014.12.014","volume":"68","author":"PC Austin","year":"2015","unstructured":"Austin PC, Steyerberg EW. The number of subjects per variable required in linear regression analyses. J Clin Epidemiol. 2015;68(6):627\u201336.","journal-title":"J Clin Epidemiol"},{"issue":"8","key":"1905_CR20","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.1093\/ndt\/gfs017","volume":"27","author":"M Caiata-Zufferey","year":"2012","unstructured":"Caiata-Zufferey M, Zanini CA, Schulz PJ, Syren ML, Bianchetti MG, Bettinelli A. Living with Gitelman disease: an insight into patients' daily experiences. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2012;27(8):3196\u2013201.","journal-title":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association."},{"issue":"1","key":"1905_CR21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4097\/kjae.2013.65.1.4","volume":"65","author":"SH Do","year":"2013","unstructured":"Do SH. Magnesium: a versatile drug for anesthesiologists. Korean J Anesthesiol. 2013;65(1):4\u20138.","journal-title":"Korean J Anesthesiol"},{"key":"1905_CR22","doi-asserted-by":"crossref","unstructured":"Boyle NB, Lawton C, Dye L. The Effects of Magnesium Supplementation on Subjective Anxiety and Stress-A Systematic Review. Nutrients. 2017;9(5).","DOI":"10.3390\/nu9050429"},{"issue":"3","key":"1905_CR23","first-page":"508","volume":"32","author":"CM Robinson","year":"2017","unstructured":"Robinson CM, Karet Frankl FE. Magnesium lactate in the treatment of Gitelman syndrome: patient-reported outcomes. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2017;32(3):508\u201312.","journal-title":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association."},{"issue":"1","key":"1905_CR24","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1159\/000046044","volume":"89","author":"H Mayan","year":"2001","unstructured":"Mayan H, Kantor R, Farfel Z. Trans-tubular potassium gradient in patients with drug-induced hyperkalemia. Nephron. 2001;89(1):56\u201361.","journal-title":"Nephron."},{"issue":"2","key":"1905_CR25","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1177\/1470320314532509","volume":"16","author":"N Kawada","year":"2015","unstructured":"Kawada N, Isaka Y, Kitamura H, Rakugi H, Moriyama T. A pilot study of the effects of eplerenone add-on therapy in patients taking renin-angiotensin system blockers. J Renin-Angiotensin-Aldosterone Syst. 2015;16(2):360\u20135.","journal-title":"J Renin-Angiotensin-Aldosterone Syst"},{"issue":"5","key":"1905_CR26","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1097\/MNH.0b013e328349b8f9","volume":"20","author":"KS Kamel","year":"2011","unstructured":"Kamel KS, Halperin ML. Intrarenal urea recycling leads to a higher rate of renal excretion of potassium: an hypothesis with clinical implications. Curr Opin Nephrol Hypertens. 2011;20(5):547\u201354.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"8","key":"1905_CR27","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1681\/ASN.2016101057","volume":"28","author":"E Seys","year":"2017","unstructured":"Seys E, Andrini O, Keck M, et al. Clinical and genetic Spectrum of Bartter syndrome type 3. J Am Soc Nephrol. 2017;28(8):2540\u201352.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"1905_CR28","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1203\/00006450-200012000-00009","volume":"48","author":"N Jeck","year":"2000","unstructured":"Jeck N, Konrad M, Peters M, Weber S, Bonzel KE, Seyberth HW. Mutations in the chloride channel gene, CLCNKB, leading to a mixed Bartter-Gitelman phenotype. Pediatr Res. 2000;48(6):754\u20138.","journal-title":"Pediatr Res"},{"key":"1905_CR29","doi-asserted-by":"crossref","unstructured":"Garcia Castano A, Perez de Nanclares G, Madariaga L, et al. Poor phenotype-genotype association in a large series of patients with Type III Bartter syndrome. PLoS One. 2017;12(3):e0173581.","DOI":"10.1371\/journal.pone.0173581"},{"issue":"5","key":"1905_CR30","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1161\/HYPERTENSIONAHA.116.08519","volume":"69","author":"N Xu","year":"2017","unstructured":"Xu N, Hirohama D, Ishizawa K, et al. Hypokalemia and Pendrin induction by aldosterone. Hypertension. 2017;69(5):855\u201362.","journal-title":"Hypertension."}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-01905-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-020-01905-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-01905-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T23:42:04Z","timestamp":1625528524000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-020-01905-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,6]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1905"],"URL":"https:\/\/doi.org\/10.1186\/s12882-020-01905-7","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,6]]},"assertion":[{"value":"21 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Obtained from Medical University of Vienna and Klinikum Klagenfurt from the associated ethics committees (EK NR 1649\/2017 and A 01\/18). Written informed consent was obtained from all participants before entering the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"256"}}